Procarbazine

Generic name: Pronounced as (proe kar' ba zeen)
Brand names
  • Matulane®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 05/15/2017

Procarbazine should be taken only under the supervision of a doctor with experience in the use of chemotherapy medications.

Keep all appointments with your doctor and the laboratory. Your doctor will order laboratory tests before, during and after your treatment to check your body's response to procarbazine.

Procarbazine is used in combination with other medications to treat certain types of Hodgkins disease (types of cancer that begin in a type of white blood cells that normally fights infection). Procarbazine is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.

Procarbazine comes as a capsule to take by mouth. It is usually taken one or more times a day. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have. Take procarbazine at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take procarbazine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Your doctor may adjust your dose of procarbazine or stop your treatment for a period of time depending on your response to treatment and any side effects that you experience. Talk to your doctor about how you are feeling during your treatment.

Procarbazine is also sometimes used in combination with other medications to treat certain types of brain tumors. Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking procarbazine,

  • tell your doctor and pharmacist if you are allergic to procarbazine, any other medications, or any of the ingredients in procarbazine capsules. Ask your pharmacist for a list of the ingredients.

  • tell your doctor if you are taking or you plan to take any of the following prescription or non-prescription medications: certain antidepressants including amitriptyline (Elavil) and imipramine (Tofranil); medications for asthma; medications for allergies, hay fever; medications containing alcohol (cough and cold products, such as Nyquil, and other liquid products); and nasal decongestants, including nose drops and sprays. Your doctor may tell you not to take these medications with procarbazine and may suggest other treatment(s).

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: barbiturate medications such as phenobarbital; medications for high blood pressure; medications for nausea or mental illness; opioid (narcotic) medications for pain; sedatives; sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with procarbazine, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you have received radiation therapy or other chemotherapy within the last 4 weeks.

  • tell your doctor if you have or have ever had kidney or liver disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. You should not become pregnant or breast-feed while you are taking procarbazine. If you become pregnant while receiving procarbazine, call your doctor. Procarbazine may harm the fetus.

  • know that you should not drink alcoholic beverages (including beer and wine) while taking this drug. Alcohol may cause an upset stomach, vomiting, stomach cramps, headaches, sweating, and flushing (redness of the face).

  • tell your doctor if you use tobacco products. Smoking may increase the risk that you will develop other cancers. You should stop smoking.

You will need to avoid eating foods that contain very high amounts of tyramine, such as certain cheeses, yogurt, and bananas during your treatment with procarbazine. Talk to your doctor or dietitian about which foods you should avoid during your treatment or if you do not feel well after eating or drinking certain foods while taking procarbazine.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Procarbazine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • loss of appetite

    • constipation

    • stomach pain

    • dryness of mouth

    • changes in skin color

    • hair loss

    • difficulty falling asleep or staying asleep

    • headache

    • bone, joint, or muscle pain

    • increased urination

  • Some side effects can be serious. If you experience any of these symptoms call your doctor immediately:

    • sores in the mouth and throat

    • severe or ongoing diarrhea

    • pain, burning, numbness, pricking, or tingling in the hands or feet or on the skin

    • uncontrollable shaking of a part of your body

    • confusion

    • hallucinating (seeing things or hearing voices that do not exist)

    • seizures

    • vision changes

    • fainting

    • dizziness

    • fast or irregular heartbeat

    • fever, sore throat, chills, or other signs of infection

    • unusual bruising or bleeding

    • black, tarry stools

    • red urine

    • hives

    • rash

    • itching

    • difficulty breathing or swallowing

    • yellowing of the skin or eyes

  • Procarbazine may increase the risk that you will develop other cancers. Talk to your doctor about this risk.

  • Procarbazine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from light, excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • nausea

  • vomiting

  • diarrhea

  • dizziness or fainting

  • uncontrollable shaking of a part of your body

  • seizures

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Repaglinide Repaglinide Procarbazine may increase the hypoglycemic activities of Repaglinide.
Montelukast Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Procarbazine.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection Procarbazine may increase the hypoglycemic activities of Insulin glargine.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Procarbazine is combined with Leflunomide.
Atorvastatin Atorvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Atorvastatin is combined with Procarbazine.
Dolasetron Dolasetron The risk or severity of adverse effects can be increased when Dolasetron is combined with Procarbazine.
Alendronate Alendronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Procarbazine.
Anagrelide Anagrelide The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Anagrelide.
Candesartan Candesartan Procarbazine may increase the hypotensive activities of Candesartan.
Cilostazol Cilostazol The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Cilostazol.
Clopidogrel Clopidogrel The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Procarbazine.
Fenofibrate Fenofibrate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Procarbazine.
Guanfacine Guanfacine Procarbazine may increase the hypotensive activities of Guanfacine.
Miglitol Miglitol Procarbazine may increase the hypoglycemic activities of Miglitol.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Procarbazine.
Nafarelin Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Procarbazine.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Naratriptan is combined with Procarbazine.
Paregoric Paregoric Procarbazine may increase the analgesic activities of Morphine.
Penbutolol Penbutolol Procarbazine may increase the hypotensive activities of Acebutolol.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Procarbazine.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Procarbazine.
Ranitidine Ranitidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Procarbazine.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Procarbazine is combined with Reserpine.
Rizatriptan Rizatriptan The metabolism of Rizatriptan can be decreased when combined with Procarbazine.
Sumatriptan Sumatriptan The metabolism of Sumatriptan can be decreased when combined with Procarbazine.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Procarbazine.
Tizanidine Tizanidine Procarbazine may increase the orthostatic hypotensive activities of Tizanidine.
Triamcinolone Triamcinolone The risk or severity of adverse effects can be increased when Triamcinolone is combined with Procarbazine.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Procarbazine.
Hydromorphone Injection Hydromorphone Injection Procarbazine may increase the serotonergic activities of Hydromorphone.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Procarbazine.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Procarbazine.
Meperidine Injection Meperidine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Procarbazine is combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Procarbazine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Metoclopramide.
Morphine Injection Morphine Injection Procarbazine may increase the analgesic activities of Morphine.
Pamidronate Injection Pamidronate Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Procarbazine.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Procarbazine.
Altretamine Altretamine Procarbazine may increase the hypertensive activities of Amphetamine.
Cyclosporine Cyclosporine Procarbazine may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Procarbazine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Procarbazine.
Torsemide Torsemide Procarbazine may increase the hypotensive activities of Torasemide.
Olanzapine Olanzapine The risk or severity of adverse effects can be increased when Olanzapine is combined with Procarbazine.
Alosetron Alosetron The risk or severity of adverse effects can be increased when Alosetron is combined with Procarbazine.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Procarbazine.
Eprosartan Eprosartan The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Procarbazine.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Procarbazine is combined with Hydroxychloroquine.
Oxcarbazepine Oxcarbazepine The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Procarbazine.
Risedronate Risedronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Procarbazine.
Telmisartan Telmisartan Procarbazine may increase the hypotensive activities of Telmisartan.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Temozolomide is combined with Procarbazine.
Zaleplon Zaleplon The risk or severity of adverse effects can be increased when Zaleplon is combined with Procarbazine.
Anakinra Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Procarbazine.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Desloratadine is combined with Procarbazine.
Linezolid Linezolid The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Procarbazine.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Pentosan polysulfate.
Trimipramine Trimipramine Procarbazine may increase the serotonergic activities of Trimipramine.
Etanercept Injection Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Procarbazine.
Glycopyrrolate Glycopyrrolate Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Perindopril Perindopril Procarbazine may increase the hypotensive activities of Perindopril.
Sirolimus Sirolimus The risk or severity of adverse effects can be increased when Sirolimus is combined with Procarbazine.
Epinephrine Injection Epinephrine Injection Procarbazine may increase the hypertensive activities of Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Procarbazine.
Eplerenone Eplerenone Procarbazine may increase the orthostatic hypotensive activities of Eplerenone.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Escitalopram.
Olmesartan Olmesartan Procarbazine may increase the hypotensive activities of Olmesartan.
Zonisamide Zonisamide The risk or severity of adverse effects can be increased when Zonisamide is combined with Procarbazine.
Adalimumab Injection Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Procarbazine.
Aripiprazole Aripiprazole The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Aripiprazole.
Atomoxetine Atomoxetine The risk or severity of adverse effects can be increased when Procarbazine is combined with Atomoxetine.
Dexmethylphenidate Dexmethylphenidate Procarbazine may increase the hypertensive activities of Dexmethylphenidate.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Glatiramer.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Procarbazine.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Procarbazine.
Mefloquine Mefloquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Procarbazine.
Rosuvastatin Rosuvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Rosuvastatin is combined with Procarbazine.
Tegaserod Tegaserod The risk or severity of serotonin syndrome can be increased when Tegaserod is combined with Procarbazine.
Tadalafil Tadalafil Procarbazine may increase the hypotensive activities of Tadalafil.
Frovatriptan Frovatriptan The risk or severity of adverse effects can be increased when Frovatriptan is combined with Procarbazine.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Apomorphine is combined with Procarbazine.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Procarbazine.
Infliximab Injection Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Procarbazine.
Protriptyline Protriptyline Procarbazine may increase the serotonergic activities of Protriptyline.
Duloxetine Duloxetine Procarbazine may increase the serotonergic activities of Duloxetine.
Trospium Trospium Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Procarbazine may increase the hypotensive activities of Bosentan.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Natalizumab.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Procarbazine is combined with Eszopiclone.
Ganciclovir Ganciclovir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Procarbazine.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection Procarbazine may increase the hypoglycemic activities of Insulin aspart.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Procarbazine.
Solifenacin Solifenacin Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Dextroamphetamine Dextroamphetamine Procarbazine may increase the hypertensive activities of Amphetamine.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Procarbazine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Procarbazine.
Pramlintide Injection Pramlintide Injection Procarbazine may increase the hypoglycemic activities of Pramlintide.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.
Exenatide Injection Exenatide Injection Procarbazine may increase the hypoglycemic activities of Exenatide.
Ibandronate Ibandronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Procarbazine.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Procarbazine is combined with Isocarboxazid.
Ramelteon Ramelteon The risk or severity of adverse effects can be increased when Ramelteon is combined with Procarbazine.
Darifenacin Darifenacin Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Procarbazine is combined with Fentanyl.
Pregabalin Pregabalin The therapeutic efficacy of Procarbazine can be increased when used in combination with Pregabalin.
Phenylephrine Phenylephrine Procarbazine may increase the hypertensive activities of Phenylephrine.
Felbamate Felbamate The risk or severity of adverse effects can be increased when Felbamate is combined with Procarbazine.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection Procarbazine may increase the hypoglycemic activities of Insulin detemir.
Abatacept Injection Abatacept Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Abatacept.
Rasagiline Rasagiline The risk or severity of adverse effects can be increased when Procarbazine is combined with Rasagiline.
Imatinib Imatinib The risk or severity of adverse effects can be increased when Imatinib is combined with Procarbazine.
Sitagliptin Sitagliptin Procarbazine may increase the hypoglycemic activities of Sitagliptin.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Procarbazine.
Albuterol Albuterol The risk or severity of adverse effects can be increased when Procarbazine is combined with Salbutamol.
Paliperidone Paliperidone The risk or severity of adverse effects can be increased when Procarbazine is combined with Paliperidone.
Bortezomib Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Procarbazine.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Procarbazine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Procarbazine.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Procarbazine.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Procarbazine.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Procarbazine.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection Procarbazine may increase the hypoglycemic activities of Insulin glulisine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Procarbazine.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Procarbazine.
Aliskiren Aliskiren Procarbazine may increase the hypotensive activities of Aliskiren.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Procarbazine.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Procarbazine.
Lisdexamfetamine Lisdexamfetamine Procarbazine may increase the hypertensive activities of Lisdexamfetamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Procarbazine is combined with Vorinostat.
Sorafenib Sorafenib The risk or severity of adverse effects can be increased when Sorafenib is combined with Procarbazine.
Sunitinib Sunitinib The risk or severity of adverse effects can be increased when Procarbazine is combined with Sunitinib.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.
Levocetirizine Levocetirizine The risk or severity of adverse effects can be increased when Procarbazine is combined with Levocetirizine.
Dasatinib Dasatinib The risk or severity of adverse effects can be increased when Procarbazine is combined with Dasatinib.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Procarbazine.
Ivermectin Ivermectin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Procarbazine.
Temsirolimus Temsirolimus The risk or severity of adverse effects can be increased when Procarbazine is combined with Temsirolimus.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Procarbazine.
Nilotinib Nilotinib The risk or severity of adverse effects can be increased when Procarbazine is combined with Nilotinib.
Raltegravir Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procarbazine is combined with Raltegravir.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Procarbazine.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Procarbazine is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Procarbazine.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Decitabine.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Procarbazine.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Procarbazine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine Procarbazine may increase the serotonergic activities of Desvenlafaxine.
Nebivolol Nebivolol Procarbazine may increase the hypotensive activities of Nebivolol.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Procarbazine.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Bendamustine.
Certolizumab Injection Certolizumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The risk or severity of adverse effects can be increased when Irinotecan is combined with Procarbazine.
Daptomycin Injection Daptomycin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Procarbazine.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Procarbazine is combined with Estramustine.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Procarbazine.
Rufinamide Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Procarbazine.
Midazolam Midazolam The risk or severity of adverse effects can be increased when Midazolam is combined with Procarbazine.
Naltrexone Injection Naltrexone Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Procarbazine.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Procarbazine.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Procarbazine.
Milnacipran Milnacipran Procarbazine may increase the serotonergic activities of Milnacipran.
Fesoterodine Fesoterodine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Betaxolol Betaxolol Procarbazine may increase the hypotensive activities of Betaxolol.
Iloperidone Iloperidone The risk or severity of adverse effects can be increased when Procarbazine is combined with Iloperidone.
Prasugrel Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Prasugrel.
Lacosamide Lacosamide The risk or severity of adverse effects can be increased when Procarbazine is combined with Lacosamide.
Everolimus Everolimus The risk or severity of adverse effects can be increased when Procarbazine is combined with Everolimus.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Procarbazine.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection The risk or severity of adverse effects can be increased when Palonosetron is combined with Procarbazine.
Saxagliptin Saxagliptin Procarbazine may increase the hypoglycemic activities of Saxagliptin.
Tapentadol Tapentadol The risk or severity of adverse effects can be increased when Tapentadol is combined with Procarbazine.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Topotecan is combined with Procarbazine.
Golimumab Injection Golimumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Golimumab.
Pazopanib Pazopanib The risk or severity of adverse effects can be increased when Procarbazine is combined with Pazopanib.
Asenapine Asenapine The risk or severity of adverse effects can be increased when Procarbazine is combined with Asenapine.
Vigabatrin Vigabatrin The risk or severity of adverse effects can be increased when Vigabatrin is combined with Procarbazine.
Pitavastatin Pitavastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procarbazine is combined with Pitavastatin.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Procarbazine.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Procarbazine.
Dabigatran Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Dabigatran.
Liraglutide Injection Liraglutide Injection Procarbazine may increase the hypoglycemic activities of Liraglutide.
Tocilizumab Injection Tocilizumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Tocilizumab.
Fingolimod Fingolimod Procarbazine may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Eribulin.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Procarbazine.
Cabazitaxel Injection Cabazitaxel Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Cabazitaxel.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Procarbazine is combined with Lurasidone.
Vilazodone Vilazodone The metabolism of Vilazodone can be decreased when combined with Procarbazine.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Procarbazine.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Procarbazine.
Terbutaline Injection Terbutaline Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Terbutaline.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Belimumab.
Azilsartan Azilsartan Procarbazine may increase the orthostatic hypotensive activities of Azilsartan medoxomil.
Busulfan Injection Busulfan Injection The risk or severity of adverse effects can be increased when Busulfan is combined with Procarbazine.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Procarbazine.
Linagliptin Linagliptin Procarbazine may increase the hypoglycemic activities of Linagliptin.
Cyclophosphamide Injection Cyclophosphamide Injection The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Procarbazine.
Rivaroxaban Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The risk or severity of adverse effects can be increased when Procarbazine is combined with Ruxolitinib.
Clobazam Clobazam The risk or severity of adverse effects can be increased when Clobazam is combined with Procarbazine.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Belatacept.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Procarbazine.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Melphalan is combined with Procarbazine.
Cabergoline Cabergoline The metabolism of Cabergoline can be decreased when combined with Procarbazine.
Ambrisentan Ambrisentan Procarbazine may increase the hypotensive activities of Ambrisentan.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Fondaparinux.
Ezogabine Ezogabine The risk or severity of adverse effects can be increased when Tiagabine is combined with Procarbazine.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Iloprost is combined with Procarbazine.
Bosutinib Bosutinib The risk or severity of adverse effects can be increased when Procarbazine is combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Procarbazine is combined with Teriflunomide.
Lorcaserin Lorcaserin Procarbazine may increase the hypoglycemic activities of Mecasermin.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Icosapent ethyl.
Tofacitinib Tofacitinib Procarbazine may increase the immunosuppressive activities of Tofacitinib.
Alogliptin Alogliptin Procarbazine may increase the hypoglycemic activities of Alogliptin.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Procarbazine is combined with Dimethyl fumarate.
Ponatinib Ponatinib The risk or severity of adverse effects can be increased when Procarbazine is combined with Ponatinib.
Pomalidomide Pomalidomide The risk or severity of adverse effects can be increased when Procarbazine is combined with Pomalidomide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Trastuzumab emtansine.
Apixaban Apixaban The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Apixaban.
Canagliflozin Canagliflozin Procarbazine may increase the orthostatic hypotensive activities of Canagliflozin.
Methazolamide Methazolamide Procarbazine may increase the orthostatic hypotensive activities of Methazolamide.
Levomilnacipran Levomilnacipran Procarbazine may increase the serotonergic activities of Levomilnacipran.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Procarbazine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Procarbazine is combined with Ibrutinib.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Obinutuzumab.
Dapagliflozin Dapagliflozin Procarbazine may increase the orthostatic hypotensive activities of Dapagliflozin.
Apremilast Apremilast The risk or severity of adverse effects can be increased when Procarbazine is combined with Apremilast.
Droxidopa Droxidopa Procarbazine may increase the hypertensive activities of Droxidopa.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Siltuximab.
Albiglutide Injection Albiglutide Injection Procarbazine may increase the hypoglycemic activities of Albiglutide.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Procarbazine is combined with Eslicarbazepine.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Belinostat.
Idelalisib Idelalisib The risk or severity of adverse effects can be increased when Procarbazine is combined with Idelalisib.
Empagliflozin Empagliflozin Procarbazine may increase the orthostatic hypotensive activities of Empagliflozin.
Vorapaxar Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Vorapaxar.
Hydrocodone Hydrocodone Procarbazine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.
Suvorexant Suvorexant Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Dulaglutide Injection Dulaglutide Injection Procarbazine may increase the hypoglycemic activities of Dulaglutide.
Edoxaban Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Peginterferon beta-1a.
Olaparib Olaparib The risk or severity of adverse effects can be increased when Procarbazine is combined with Olaparib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Blinatumomab.
Methamphetamine Methamphetamine Procarbazine may increase the hypertensive activities of Metamfetamine.
Tasimelteon Tasimelteon The risk or severity of adverse effects can be increased when Procarbazine is combined with Tasimelteon.
Riociguat Riociguat Procarbazine may increase the hypotensive activities of Riociguat.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Procarbazine is combined with Pirfenidone.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of adverse effects can be increased when Risperidone is combined with Procarbazine.
Palbociclib Palbociclib The risk or severity of adverse effects can be increased when Procarbazine is combined with Palbociclib.
Insulin Human Inhalation Insulin Human Inhalation Procarbazine may increase the hypoglycemic activities of Insulin human.
Panobinostat Panobinostat The risk or severity of adverse effects can be increased when Procarbazine is combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of CNS depression can be increased when Procarbazine is combined with Haloperidol.
Amiloride Amiloride Procarbazine may increase the orthostatic hypotensive activities of Amiloride.
Macitentan Macitentan Procarbazine may increase the hypotensive activities of Macitentan.
Flibanserin Flibanserin The metabolism of Flibanserin can be decreased when combined with Procarbazine.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Prednisolone is combined with Procarbazine.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Procarbazine.
Ziprasidone Injection Ziprasidone Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Ziprasidone.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Procarbazine.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection Procarbazine may increase the hypoglycemic activities of Insulin degludec.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Trabectedin.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Procarbazine.
Dexamethasone Injection Dexamethasone Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Dexamethasone.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Defibrotide.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Brivaracetam.
Midodrine Midodrine Procarbazine may increase the hypertensive activities of Midodrine.
Selexipag Selexipag Procarbazine may increase the hypotensive activities of Selexipag.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Procarbazine is combined with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Procarbazine may increase the orthostatic hypotensive activities of Furosemide.
Lixisenatide Injection Lixisenatide Injection Procarbazine may increase the hypoglycemic activities of Lixisenatide.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Brodalumab.
Doxepin (Insomnia) Doxepin (Insomnia) Procarbazine may increase the serotonergic activities of Doxepin.
Deutetrabenazine Deutetrabenazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Deutetrabenazine.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Procarbazine is combined with Deflazacort.
Safinamide Safinamide The risk or severity of adverse effects can be increased when Procarbazine is combined with Safinamide.
Ocrelizumab Injection Ocrelizumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Ocrelizumab.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Sarilumab.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Guselkumab.
Betrixaban Betrixaban The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Betrixaban.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Procarbazine.
Semaglutide Injection Semaglutide Injection Procarbazine may increase the hypoglycemic activities of Semaglutide.
Tetrabenazine Tetrabenazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Procarbazine may increase the hypoglycemic activities of Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The risk or severity of serotonin syndrome and opioid toxicity can be increased when Buprenorphine is combined with Procarbazine.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Penicillamine is combined with Procarbazine.
Baricitinib Baricitinib The risk or severity of adverse effects can be increased when Procarbazine is combined with Baricitinib.
Lofexidine Lofexidine The therapeutic efficacy of Procarbazine can be increased when used in combination with Lofexidine.
Cannabidiol Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Procarbazine.
Stiripentol Stiripentol The risk or severity of adverse effects can be increased when Procarbazine is combined with Stiripentol.
Gilteritinib Gilteritinib The therapeutic efficacy of Procarbazine can be decreased when used in combination with Gilteritinib.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Procarbazine.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Paclitaxel.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Procarbazine is combined with Siponimod.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Caplacizumab.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Risankizumab.
Brexanolone Injection Brexanolone Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Brexanolone.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Procarbazine.
Solriamfetol Solriamfetol The risk or severity of adverse effects can be increased when Procarbazine is combined with Solriamfetol.
Phenytoin Injection Phenytoin Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Procarbazine.
Fosphenytoin Injection Fosphenytoin Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Fosphenytoin.
Lumateperone Lumateperone The risk or severity of adverse effects can be increased when Procarbazine is combined with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Lasmiditan.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Procarbazine is combined with Ozanimod.
Lemborexant Lemborexant The risk or severity of adverse effects can be increased when Procarbazine is combined with Lemborexant.
Fenfluramine Fenfluramine The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Procarbazine.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Viloxazine.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Procarbazine.
Trazodone Trazodone Procarbazine may increase the serotonergic activities of Trazodone.
Isotretinoin Isotretinoin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Procarbazine.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Procarbazine.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Procarbazine.
Phenobarbital Phenobarbital The risk or severity of adverse effects can be increased when Procarbazine is combined with Phenobarbital.
Metaxalone Metaxalone The risk or severity of adverse effects can be increased when Metaxalone is combined with Procarbazine.
Methotrexate Injection Methotrexate Injection The risk or severity of adverse effects can be increased when Methotrexate is combined with Procarbazine.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Procarbazine.
Primidone Primidone The risk or severity of adverse effects can be increased when Primidone is combined with Procarbazine.
Methsuximide Methsuximide The risk or severity of adverse effects can be increased when Procarbazine is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Procarbazine is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The risk or severity of extrapyramidal symptoms can be increased when Chlorpromazine is combined with Procarbazine.
Diazepam Diazepam The risk or severity of adverse effects can be increased when Diazepam is combined with Procarbazine.
Oxazepam Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Procarbazine.
Flurazepam Flurazepam The risk or severity of adverse effects can be increased when Flurazepam is combined with Procarbazine.
Clorazepate Clorazepate The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Procarbazine.
Lorazepam Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Procarbazine.
Phenoxybenzamine Phenoxybenzamine Procarbazine may increase the hypotensive activities of Phenoxybenzamine.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Procarbazine.
Amantadine Amantadine The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Procarbazine.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Procarbazine.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Procarbazine.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Procarbazine.
Bromocriptine Bromocriptine Procarbazine may increase the hypertensive activities of Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of adverse effects can be increased when Procarbazine is combined with Orciprenaline.
Tranylcypromine Tranylcypromine The risk or severity of adverse effects can be increased when Procarbazine is combined with Tranylcypromine.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Phenelzine is combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Procarbazine.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Procarbazine.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.
Prochlorperazine Prochlorperazine The risk or severity of extrapyramidal symptoms can be increased when Procarbazine is combined with Prochlorperazine.
Thioridazine Thioridazine The risk or severity of extrapyramidal symptoms can be increased when Thioridazine is combined with Procarbazine.
Trifluoperazine Trifluoperazine The risk or severity of extrapyramidal symptoms can be increased when Procarbazine is combined with Trifluoperazine.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Procarbazine.
Sulfadiazine Sulfadiazine Procarbazine may increase the hypoglycemic activities of Sulfadiazine.
Oxycodone Oxycodone Procarbazine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Procarbazine.
Oxybutynin Oxybutynin Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
Maprotiline Maprotiline The risk or severity of adverse effects can be increased when Procarbazine is combined with Maprotiline.
Trihexyphenidyl Trihexyphenidyl Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The risk or severity of extrapyramidal symptoms can be increased when Procarbazine is combined with Perphenazine.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Azathioprine is combined with Procarbazine.
Fluphenazine Fluphenazine The risk or severity of extrapyramidal symptoms can be increased when Procarbazine is combined with Fluphenazine.
Phentermine Phentermine Procarbazine may increase the hypertensive activities of Phentermine.
Methylphenidate Methylphenidate Procarbazine may increase the hypertensive activities of Methylphenidate.
Amoxapine Amoxapine The risk or severity of adverse effects can be increased when Procarbazine is combined with Amoxapine.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Procarbazine.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Procarbazine is combined with Lomustine.
Doxorubicin Doxorubicin The risk or severity of adverse effects can be increased when Doxorubicin is combined with Procarbazine.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Cytarabine is combined with Procarbazine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Procarbazine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Dactinomycin is combined with Procarbazine.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Procarbazine.
Molindone Molindone The risk or severity of adverse effects can be increased when Procarbazine is combined with Molindone.
Methyldopa Methyldopa Procarbazine may decrease the hypotensive activities of Methyldopa.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Procarbazine.
Prazosin Prazosin Procarbazine may increase the hypotensive activities of Prazosin.
Hydralazine Hydralazine Procarbazine may increase the hypotensive activities of Hydralazine.
Cimetidine Cimetidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cimetidine is combined with Procarbazine.
Warfarin Warfarin The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Warfarin.
Clonazepam Clonazepam The risk or severity of adverse effects can be increased when Clonazepam is combined with Procarbazine.
Promethazine Promethazine The risk or severity of extrapyramidal symptoms can be increased when Promethazine is combined with Procarbazine.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Procarbazine.
Loxapine Loxapine The risk or severity of adverse effects can be increased when Loxapine is combined with Procarbazine.
Chloroquine Chloroquine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Procarbazine.
Quinine Quinine The risk or severity of adverse effects can be increased when Quinine is combined with Procarbazine.
Ethosuximide Ethosuximide The risk or severity of adverse effects can be increased when Ethosuximide is combined with Procarbazine.
Triamterene Triamterene Procarbazine may increase the orthostatic hypotensive activities of Triamterene.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide Procarbazine may increase the hypotensive activities of Chlorothiazide.
Chlorthalidone Chlorthalidone Procarbazine may increase the hypotensive activities of Chlorthalidone.
Metolazone Metolazone Procarbazine may increase the hypotensive activities of Metolazone.
Secobarbital Secobarbital The risk or severity of adverse effects can be increased when Secobarbital is combined with Procarbazine.
Desipramine Desipramine Procarbazine may increase the serotonergic activities of Desipramine.
Amitriptyline Amitriptyline Procarbazine may increase the serotonergic activities of Amitriptyline.
Imipramine Imipramine Procarbazine may increase the serotonergic activities of Imipramine.
Quinidine Quinidine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.
Procainamide Procainamide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procainamide is combined with Procarbazine.
Isoniazid Isoniazid The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isoniazid is combined with Procarbazine.
Disopyramide Disopyramide Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.
Valproic Acid Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Procarbazine.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Procarbazine.
Butabarbital Butabarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Procarbazine.
Methimazole Methimazole The risk or severity of adverse effects can be increased when Methimazole is combined with Procarbazine.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Procarbazine.
Chlorpropamide Chlorpropamide Procarbazine may increase the hypoglycemic activities of Chlorpropamide.
Tolbutamide Tolbutamide Procarbazine may increase the hypoglycemic activities of Tolbutamide.
Tolazamide Tolazamide Procarbazine may increase the hypoglycemic activities of Tolazamide.
Dextromethorphan Dextromethorphan The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine Cyclobenzaprine may increase the serotonergic activities of Procarbazine.
Niacin Niacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Procarbazine.
Baclofen Baclofen The risk or severity of hypotension can be increased when Baclofen is combined with Procarbazine.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.
Cyproheptadine Cyproheptadine Procarbazine may increase the anticholinergic activities of Cyproheptadine.
Clemastine Clemastine Procarbazine may increase the anticholinergic activities of Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Procarbazine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Procarbazine.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Meclizine is combined with Procarbazine.
Methyclothiazide Methyclothiazide Procarbazine may increase the orthostatic hypotensive activities of Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide Procarbazine may increase the hypotensive activities of Hydrochlorothiazide.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Procarbazine is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Procarbazine.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Procarbazine.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Procarbazine.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Procarbazine may increase the hypotensive activities of Propranolol.
Minoxidil Minoxidil Procarbazine may increase the hypotensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine Procarbazine may increase the hypertensive activities of Pseudoephedrine.
Nortriptyline Nortriptyline Procarbazine may increase the serotonergic activities of Nortriptyline.
Spironolactone Spironolactone Procarbazine may increase the orthostatic hypotensive activities of Spironolactone.
Amphotericin B Injection Amphotericin B Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Procarbazine.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Procarbazine.
Nadolol Nadolol Procarbazine may increase the hypotensive activities of Nadolol.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Procarbazine.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Procarbazine.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Procarbazine.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Procarbazine.
Flavoxate Flavoxate Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine Procarbazine may increase the orthostatic hypotensive activities of Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Procarbazine.
Colchicine Colchicine The risk or severity of adverse effects can be increased when Procarbazine is combined with Colchicine.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Dacarbazine is combined with Procarbazine.
Acetazolamide Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Procarbazine.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Procarbazine.
Pyrantel Pyrantel The risk or severity of adverse effects can be increased when Procarbazine is combined with Pyrantel.
Thiotepa Injection Thiotepa Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Thiotepa.
Vincristine Injection Vincristine Injection The risk or severity of adverse effects can be increased when Vincristine is combined with Procarbazine.
Captopril Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procarbazine is combined with Captopril.
Dipyridamole Dipyridamole Procarbazine may increase the orthostatic hypotensive activities of Dipyridamole.
Isoxsuprine Isoxsuprine Procarbazine may increase the orthostatic hypotensive activities of Isoxsuprine.
Vinblastine Vinblastine The risk or severity of adverse effects can be increased when Vinblastine is combined with Procarbazine.
Ethacrynic Acid Ethacrynic Acid Procarbazine may increase the orthostatic hypotensive activities of Etacrynic acid.
Metoprolol Metoprolol Procarbazine may increase the hypotensive activities of Metoprolol.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Procarbazine.
Thiothixene Thiothixene The risk or severity of adverse effects can be increased when Procarbazine is combined with Thiothixene.
Aspirin Aspirin The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Acetylsalicylic acid.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Procarbazine.
Alprazolam Alprazolam The risk or severity of adverse effects can be increased when Alprazolam is combined with Procarbazine.
Temazepam Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Procarbazine.
Triazolam Triazolam The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Procarbazine.
Dicyclomine Dicyclomine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Trimethoprim Trimethoprim The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Procarbazine.
Diltiazem Diltiazem Procarbazine may increase the hypotensive activities of Diltiazem.
Nifedipine Nifedipine Procarbazine may increase the orthostatic hypotensive activities of Nifedipine.
Timolol Timolol Procarbazine may increase the hypotensive activities of Timolol.
Verapamil Verapamil Procarbazine may increase the orthostatic hypotensive activities of Verapamil.
Atenolol Atenolol Procarbazine may increase the hypotensive activities of Atenolol.
Pindolol Pindolol Procarbazine may increase the hypotensive activities of Pindolol.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Procarbazine.
Bumetanide Bumetanide The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Procarbazine.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Procarbazine.
Etoposide Etoposide The risk or severity of adverse effects can be increased when Etoposide is combined with Procarbazine.
Glyburide Glyburide Procarbazine may increase the hypoglycemic activities of Glyburide.
Glipizide Glipizide Procarbazine may increase the hypoglycemic activities of Glipizide.
Indapamide Indapamide Procarbazine may increase the hypotensive activities of Indapamide.
Pentoxifylline Pentoxifylline The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Pentoxifylline.
Pentamidine Injection Pentamidine Injection Procarbazine may increase the hypoglycemic activities of Pentamidine.
Labetalol Labetalol Procarbazine may increase the hypotensive activities of Labetalol.
Leuprolide Injection Leuprolide Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Procarbazine.
Gemfibrozil Gemfibrozil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procarbazine is combined with Gemfibrozil.
Guanabenz Guanabenz Procarbazine may increase the hypotensive activities of Guanabenz.
Pimozide Pimozide The risk or severity of adverse effects can be increased when Procarbazine is combined with Pimozide.
Enalapril Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Procarbazine.
Amiodarone Amiodarone The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Procarbazine.
Buspirone Buspirone The risk or severity of hypertension can be increased when Procarbazine is combined with Buspirone.
Lovastatin Lovastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Procarbazine.
Ciprofloxacin Ciprofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Procarbazine.
Fluoxetine Fluoxetine The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Fluoxetine.
Nimodipine Nimodipine Procarbazine may increase the hypotensive activities of Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Procarbazine.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Procarbazine is combined with Clozapine.
Estazolam Estazolam The risk or severity of adverse effects can be increased when Procarbazine is combined with Estazolam.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Procarbazine is combined with Idarubicin.
Ofloxacin Ofloxacin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Procarbazine.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Fludarabine is combined with Procarbazine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Procarbazine.
Benazepril Benazepril Procarbazine may increase the hypotensive activities of Benazepril.
Felodipine Felodipine Procarbazine may increase the hypotensive activities of Felodipine.
Fosinopril Fosinopril Procarbazine may increase the hypotensive activities of Fosinopril.
Pravastatin Pravastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Procarbazine.
Quinapril Quinapril Procarbazine may increase the hypotensive activities of Quinapril.
Ramipril Ramipril Procarbazine may increase the hypotensive activities of Ramipril.
Simvastatin Simvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Simvastatin is combined with Procarbazine.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Procarbazine.
Amlodipine Amlodipine Procarbazine may increase the hypotensive activities of Amlodipine.
Teniposide Injection Teniposide Injection The risk or severity of adverse effects can be increased when Teniposide is combined with Procarbazine.
Lisinopril Lisinopril Procarbazine may increase the hypotensive activities of Lisinopril.
Sotalol Sotalol Procarbazine may increase the orthostatic hypotensive activities of Sotalol.
Bisoprolol Bisoprolol Procarbazine may increase the hypotensive activities of Bisoprolol.
Zolpidem Zolpidem Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin Procarbazine may increase the hypotensive activities of Doxazosin.
Terazosin Terazosin Procarbazine may increase the hypotensive activities of Terazosin.
Isradipine Isradipine Procarbazine may increase the hypotensive activities of Isradipine.
Cisapride Cisapride The risk or severity of adverse effects can be increased when Cisapride is combined with Procarbazine.
Gabapentin Gabapentin The risk or severity of adverse effects can be increased when Gabapentin is combined with Procarbazine.
Fluvastatin Fluvastatin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fluvastatin is combined with Procarbazine.
Venlafaxine Venlafaxine Procarbazine may increase the serotonergic activities of Venlafaxine.
Nizatidine Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Procarbazine.
Stavudine Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Procarbazine.
Fluvoxamine Fluvoxamine Procarbazine may increase the serotonergic activities of Fluvoxamine.
Nefazodone Nefazodone Procarbazine may increase the serotonergic activities of Nefazodone.
Lamotrigine Lamotrigine The risk or severity of adverse effects can be increased when Lamotrigine is combined with Procarbazine.
Losartan Losartan Procarbazine may increase the hypotensive activities of Losartan.
Tramadol Tramadol The risk or severity of serotonin syndrome and seizure can be increased when Procarbazine is combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Procarbazine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Carboplatin is combined with Procarbazine.
Moexipril Moexipril Procarbazine may increase the hypotensive activities of Moexipril.
Ifosfamide Injection Ifosfamide Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Ifosfamide.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Procarbazine.
Nicardipine Nicardipine Procarbazine may increase the hypotensive activities of Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Procarbazine is combined with Bupropion.
Ticlopidine Ticlopidine The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Ticlopidine.
Saquinavir Saquinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procarbazine is combined with Saquinavir.
Metformin Metformin Procarbazine may increase the hypoglycemic activities of Metformin.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Dalteparin.
Nisoldipine Nisoldipine Procarbazine may increase the hypotensive activities of Nisoldipine.
Lamivudine Lamivudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Procarbazine.
Riluzole Riluzole The risk or severity of adverse effects can be increased when Riluzole is combined with Procarbazine.
Amifostine Injection Amifostine Injection Procarbazine may increase the orthostatic hypotensive activities of Amifostine.
Acarbose Acarbose Procarbazine may increase the hypoglycemic activities of Acarbose.
Glimepiride Glimepiride Procarbazine may increase the hypoglycemic activities of Glimepiride.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Procarbazine.
Indinavir Indinavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Procarbazine.
Ritonavir Ritonavir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ritonavir is combined with Procarbazine.
Docetaxel Injection Docetaxel Injection The risk or severity of adverse effects can be increased when Procarbazine is combined with Docetaxel.
Clomipramine Clomipramine Procarbazine may increase the serotonergic activities of Clomipramine.
Mirtazapine Mirtazapine Procarbazine may increase the serotonergic activities of Mirtazapine.
Trandolapril Trandolapril Procarbazine may increase the hypotensive activities of Trandolapril.
Topiramate Topiramate The risk or severity of adverse effects can be increased when Topiramate is combined with Procarbazine.
Valsartan Valsartan Procarbazine may increase the hypotensive activities of Valsartan.
Insulin Lispro Injection Insulin Lispro Injection Procarbazine may increase the hypoglycemic activities of Insulin lispro.
Pramipexole Pramipexole Procarbazine may increase the sedative activities of Pramipexole.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Donepezil is combined with Procarbazine.
Carvedilol Carvedilol Procarbazine may increase the hypotensive activities of Carvedilol.
Selegiline Selegiline The risk or severity of adverse effects can be increased when Selegiline is combined with Procarbazine.
Sertraline Sertraline The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Sertraline.
Letrozole Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Letrozole is combined with Procarbazine.
Irbesartan Irbesartan Procarbazine may increase the hypotensive activities of Irbesartan.
Tamsulosin Tamsulosin Procarbazine may increase the orthostatic hypotensive activities of Tamsulosin.
Ropinirole Ropinirole Procarbazine may increase the sedative activities of Ropinirole.
Quetiapine Quetiapine The risk or severity of adverse effects can be increased when Procarbazine is combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of adverse effects can be increased when Cetirizine is combined with Procarbazine.
Paroxetine Paroxetine Procarbazine may increase the serotonergic activities of Paroxetine.
Tolcapone Tolcapone Procarbazine may increase the orthostatic hypotensive activities of Tolcapone.
Citalopram Citalopram The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Citalopram.
Capecitabine Capecitabine The risk or severity of adverse effects can be increased when Capecitabine is combined with Procarbazine.
Efavirenz Efavirenz The risk or severity of adverse effects can be increased when Efavirenz is combined with Procarbazine.
Sildenafil Sildenafil The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Procarbazine.
Pioglitazone Pioglitazone Procarbazine may increase the hypoglycemic activities of Pioglitazone.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Procarbazine.
Rosiglitazone Rosiglitazone Procarbazine may increase the hypoglycemic activities of Rosiglitazone.
Tolterodine Tolterodine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide Thalidomide Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Nateglinide Nateglinide Procarbazine may increase the hypoglycemic activities of Nateglinide.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Procarbazine is combined with Levetiracetam.
Terbinafine Terbinafine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Procarbazine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists